Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    July 2017
  1. GALVAN DL, Badal SS, Long J, Chang BH, et al
    Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30355.
    PubMed     Text format     Abstract available


  2. LIANG G, Song L, Chen Z, Qian Y, et al
    Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30353.
    PubMed     Text format     Abstract available


  3. GALSGAARD J, Persson F, Hansen TW, Jorsal A, et al
    Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Kidney Int. 2017 Jul 13. pii: S0085-2538(17)30310.
    PubMed     Text format     Abstract available


  4. LOOKER HC, Nelson RG
    Reading the tree leaves-how to enrich clinical trials of diabetic kidney disease.
    Kidney Int. 2017;92:23-25.
    PubMed     Text format     Abstract available


  5. GALVAN DL, Danesh FR
    beta2-adrenergic receptors in inflammation and vascular complications of diabetes.
    Kidney Int. 2017;92:14-16.
    PubMed     Text format     Abstract available


    June 2017
  6. WEN CP, Chang CH, Tsai MK, Lee JH, et al
    Diabetes with early kidney involvement may shorten life expectancy by 16 years.
    Kidney Int. 2017 Jun 1. pii: S0085-2538(17)30095.
    PubMed     Text format     Abstract available


    May 2017
  7. ZHANG H, Nair V, Saha J, Atkins KB, et al
    Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.
    Kidney Int. 2017 May 26. pii: S0085-2538(17)30230.
    PubMed     Text format     Abstract available



  8. Oellgaard J, Gaede P, Rossing P, et al. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney Int. 2017;91:982-988.
    Kidney Int. 2017;91:1257.
    PubMed     Text format    


  9. GUL A, Harford A, Zager P
    Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics.
    Kidney Int. 2017;91:1005-1007.
    PubMed     Text format     Abstract available


    April 2017
  10. HOSHINO J, Larkina M, Karaboyas A, Bieber BA, et al
    Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30110.
    PubMed     Text format     Abstract available


  11. NOH H, Yu MR, Kim HJ, Lee JH, et al
    Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30118.
    PubMed     Text format     Abstract available


  12. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    PubMed     Text format     Abstract available


  13. HOY WE, Kopp JB, Mott SA, Winkler CA, et al
    Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.
    Kidney Int. 2017;91:990.
    PubMed     Text format    


  14. WYATT CM
    Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?
    Kidney Int. 2017;91:766-768.
    PubMed     Text format     Abstract available


    March 2017
  15. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


  16. ZHANG L, Zhang Q, Liu S, Chen Y, et al
    DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30037.
    PubMed     Text format     Abstract available


    February 2017
  17. AHOLA AJ, Sandholm N, Forsblom C, Harjutsalo V, et al
    The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Kidney Int. 2017 Feb 21. pii: S0085-2538(16)30757.
    PubMed     Text format     Abstract available


  18. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Text format     Abstract available


    January 2017
  19. KLEMIS V, Ghura H, Federico G, Wurfel C, et al
    Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Kidney Int. 2017 Jan 31. pii: S0085-2538(16)30706.
    PubMed     Text format     Abstract available


  20. KHOSITSETH S, Charngkaew K, Boonkrai C, Somparn P, et al
    Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus.
    Kidney Int. 2017 Jan 27. pii: S0085-2538(16)30704.
    PubMed     Text format     Abstract available


  21. LI HY, Oh YS, Choi JW, Jung JY, et al
    Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Kidney Int. 2017 Jan 19. pii: S0085-2538(16)30681.
    PubMed     Text format     Abstract available


    December 2016
  22. SOLEIMANI A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, et al
    Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30592.
    PubMed     Text format     Abstract available


  23. WYSOCKI J, Ye M, Khattab AM, Fogo A, et al
    Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30565.
    PubMed     Text format     Abstract available


  24. PERKOVIC V, Agarwal R, Fioretto P, Hemmelgarn BR, et al
    Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Kidney Int. 2016;90:1175-1183.
    PubMed     Text format     Abstract available


    November 2016
  25. SCIALLA JJ, Asplin J, Dobre M, Chang AR, et al
    Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30538.
    PubMed     Text format     Abstract available


  26. YOU H, Gao T, Raup-Konsavage WM, Cooper TK, et al
    Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30598.
    PubMed     Text format     Abstract available


    September 2016
  27. SUGATANI T, Agapova OA, Fang Y, Berman AG, et al
    Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30425.
    PubMed     Text format     Abstract available



  28. Pavkov ME, Weil EJ, Fufaa GD, et al. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016;89:226-234.
    Kidney Int. 2016;90:709.
    PubMed     Text format    


    August 2016
  29. KUWAGATA S, Kume S, Chin-Kanasaki M, Araki H, et al
    MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells.
    Kidney Int. 2016 Aug 30. pii: S0085-2538(16)30344.
    PubMed     Text format     Abstract available


  30. GARSEN M, Rops AL, Dijkman H, Willemsen B, et al
    Cathepsin L is crucial for the development of early experimental diabetic nephropathy.
    Kidney Int. 2016 Aug 26. pii: S0085-2538(16)30343.
    PubMed     Text format     Abstract available


  31. LIU W, Yang Y, Liu Y, Lu X, et al
    Exogenous kallikrein protects against diabetic nephropathy.
    Kidney Int. 2016 Aug 18. pii: S0085-2538(16)30307.
    PubMed     Text format     Abstract available


  32. KLEIN J, Ramirez-Torres A, Ericsson A, Huang Y, et al
    Urinary peptidomics provides a noninvasive humanized readout of diabetic nephropathy in mice.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30313.
    PubMed     Text format     Abstract available


    July 2016
  33. TAKASHIMA S, Fujita H, Fujishima H, Shimizu T, et al
    Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
    Kidney Int. 2016 Jul 27. pii: S0085-2538(16)30273.
    PubMed     Text format     Abstract available


  34. DELANGHE JR, Delanghe SE, De Buyzere ML, Speeckaert MM, et al
    Infrared spectroscopic imaging for interrogating the carbohydrate biochemistry of diabetic nephropathy progression.
    Kidney Int. 2016;90:225-6.
    PubMed     Text format    


  35. SAID SM, Nasr SH
    Silent diabetic nephropathy.
    Kidney Int. 2016;90:24-6.
    PubMed     Text format     Abstract available


  36. WYATT CM, Cattran DC
    Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
    Kidney Int. 2016;90:8-10.
    PubMed     Text format     Abstract available


    June 2016
  37. WHEELER DC, Kasiske BL
    Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study.
    Kidney Int. 2016;89:1189-91.
    PubMed     Text format     Abstract available


    May 2016
  38. COUGHLAN MT, Sharma K
    Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease.
    Kidney Int. 2016 May 20. pii: S0085-2538(16)30111.
    PubMed     Text format     Abstract available


  39. ERIKSEN BO, Stefansson VT, Jenssen TG, Mathisen UD, et al
    Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30073.
    PubMed     Text format     Abstract available


  40. KLEIN J, Bascands JL, Buffin-Meyer B, Schanstra JP, et al
    Epidermal growth factor and kidney disease: a long-lasting story.
    Kidney Int. 2016;89:985-7.
    PubMed     Text format     Abstract available


  41. TERRYN S, Tanaka K, Lengele JP, Olinger E, et al
    Tubular proteinuria in patients with HNF1alpha mutations: HNF1alpha drives endocytosis in the proximal tubule.
    Kidney Int. 2016;89:1075-89.
    PubMed     Text format     Abstract available


    April 2016
  42. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    PubMed     Text format     Abstract available


  43. KLESSENS CQ, Woutman TD, Veraar KA, Zandbergen M, et al
    An autopsy study suggests that diabetic nephropathy is underdiagnosed.
    Kidney Int. 2016 Apr 9. pii: S0085-2538(16)00313.
    PubMed     Text format     Abstract available


    February 2016
  44. DE MARINIS Y, Cai M, Bompada P, Atac D, et al
    Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
    Kidney Int. 2016;89:342-53.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: